Bayer's much-anticipated stem cell therapy for Parkinson's disease is gathering momentum, with dosing in phase 3 trials now underway. The first patient has already been treated with bemdaneprocel, a ...
Wearable technology developer Biolinq has won FDA authorisation for a biosensor that can measure glucose levels continuously just beneath the skin's surface, without the need for a needle. The San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback